explore -WSS

explore

author：comprehensive 2025-09-27 19:37:44 - browse：6

Cambridge: AbbVie — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Military medical care influenced by rank and race, new study finds

WSS

In early work, researchers turn to CRISPR to treat Alzheimer's

FDA approves RSV monoclonal antibody for infants, toddlers

Group opposing PBM reform sets lobbying record

Group opposing PBM reform sets lobbying record

How dance can help nurses traumatized by Covid

A public scorecard can help hold safety

focus

explore

focus

Continuity nursing helped my family in our darkest PICU moments

When prostate cancer spreads, where it goes matters

Heart attack and stroke risk calculators need revising

How Medicaid coverage policies for immigrants impact new moms

BioMarin wins approval for gene therapy to treat hemophilia A

NVIDIA and Google execs on the future of AI and drug discovery

Cancer drug shortages should be causing more outrage

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Medicare proposal to cover medical devices draws a mixed reaction

How dance can help nurses traumatized by Covid

leisure time

When prostate cancer spreads, where it goes matters

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Doctors find melanoma drugs effective against rare brain cancer

A public scorecard can help hold safety

Medicare has a new plan to address drug shortages

Case highlights the risks of experimental stem cell therapy

hotspot

entertainment

explore

explore